Breast Cancer Screening Attendance Helps Boost Other Cancer Screenings

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Aug. 14, 2024 -- Offering self-sampling kits to women overdue for cervical cancer (CC) or colorectal cancer (CRC) screening when they attend breast cancer (BC) screening can result in increased screening participation, according to a study published online Aug. 13 in PLOS Medicine.

Anne Dorte Lerche Helgestad, from Randers Regional Hospital in Denmark, and colleagues assessed the effectiveness of leveraging the high participation rate in BC screening to offer self-sampling kits to nonparticipants in CC and CRC screening. The analysis included 27,116 women (aged 50 to 69 years) attending BC screening on one of 100 weekdays at five screening units.

The researchers found that six months after the intervention, total coverage was significantly higher in the intervention group versus the control group (offered standard screening) for CC screening (88.3 versus 83.5 percent) and CRC screening (79.8 versus 76.0 percent). For women overdue for CC screening, participation in the intervention group was 32.0 percent versus 6.1 percent in the control group. For those with overdue CRC screening, participation in the intervention group was 23.8 percent, versus 8.9 percent in the control group.

"This study suggests that combining preventive services may offer a pragmatic strategy to enhancing the effectiveness of public health interventions in various settings," the authors write. "The intervention strategy can be easily expanded and could increase screening participation if implemented on a larger scale."

Several authors disclosed ties to Roche Diagnostics.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords